Peptides DB
Research-centric peptide and protocol reference hub
Study 2 of 22KPV literaturePubMed · Review2025

Exploring the Role of Tripeptides in Wound Healing and Skin Regeneration: A Comprehensive Review.

Tripeptides like KPV may have roles in wound healing, but specific evidence and numeric outcomes are not detailed in this review.

Read at PubMedAdd to compare

Where it sits

this study against the rest of the kpv corpus
2
Preclinical
14
Observational
0
Open-label
3
Randomised
3
Reviews · this one

Summary and findings

This review explores the role of tripeptides, including KPV, in wound healing and skin regeneration. It discusses their biological functions, mechanisms of action, and therapeutic applications based on studies published between 2016 and 2025. No specific numeric findings or doses were reported in the abstract.

How much of this paper we could read: title only (0.30). The feed gave us little more than the title, so our summary is thin. This says nothing about the study's quality — read the source. What this means →
2025

Abstract

The authors’ words, as PubMed supplied them

Wound healing is a complex and dynamic process that requires the coordination of cellular, molecular, and physiological events to restore tissue integrity. Despite notable advances in treatment strategies, optimizing healing outcomes, particularly in chronic wounds, remains a major challenge. Emerging evidence highlights the therapeutic promise of peptides, especially tripeptides, in accelerating tissue repair through diverse mechanisms. These short peptides regulate key processes such as cell migration, proliferation, and differentiation, while also modulating inflammation, promoting angiogenesis, and facilitating extracellular matrix (ECM) remodeling. This review, covering studies published between 2016 and 2025, explores the role of tripeptides in enhancing wound repair, emphasizing their biological functions, mechanisms of action, and therapeutic applications. Recent findings demonstrate that tripeptides can stimulate fibroblast migration, enhance collagen deposition, and support angiogenesis. In addition, they exhibit antimicrobial and anti-inflammatory properties, making them valuable candidates for both acute and chronic wound management. GHK-based formulations, including nanoparticle conjugates, hydrogels, and clinical derivatives such as TriHex and TriHex 2.0, enhance fibroblast migration, ECM remodeling, collagen and elastin synthesis, and wound closure while providing antimicrobial activity. KdPT mitigates hyperglycemia-induced oxidative stress and restores keratinocyte function, whereas KPV-loaded hydrogels reduce inflammation, promote tissue regeneration, and combat MRSA infections. Additionally, lipotripeptides (DICAMs) inhibit and disrupt bacterial biofilms, and GPE supports neuroprotection and regeneration through ERK and PI3K/Akt signaling activation. Beyond wound repair, this review also discusses comparative physicochemical properties and wound healing applications of tripeptides versus larger peptides, factors influencing their performance, strategies for combination with biomaterial scaffolds, and emerging applications in fields such as cancer and cosmetics. Collectively, tripeptides represent a promising class of multifunctional bioactive molecules in wound care, offering novel avenues for targeted tissue regeneration. Future research should focus on improving their stability, bioavailability, and delivery systems to fully harness their clinical potential in regenerative medicine.

Background

Not reported in abstract.

Methods

Not reported in abstract.

Results

Not reported in abstract.

Interpretation

Not reported in abstract.

Key findings

  • Not reported in abstract.
  • Not reported in abstract.
  • Not reported in abstract.

Limitations

  • Not reported in abstract.
  • Not reported in abstract.

Elsewhere in the KPV corpus

CCritical role of PepT1 in promoting colitis-associated cancer and therapeutic benefits of the anti-inflammatory PepT1-mediated tripeptide KPV in a murine model.Cellular and molecular gastroenterology and hepatology · 2016 · Not reported in abstract.AnimalBCauses and timing of death in extremely premature infants from 2000 through 2011.The New England journal of medicine · 2015 · 275 deaths per 1000 live births from 2000 through 2003, 95% CI 264 to 285.HumanAHydrocortisone to Improve Survival without Bronchopulmonary Dysplasia.The New England journal of medicine · 2022 · Survival without moderate or severe bronchopulmonary dysplasia at 36 weeks was 16.6% in the hydrocortisone group and 13.2% in the placebo group.HumanATrial of Erythropoietin for Hypoxic-Ischemic Encephalopathy in Newborns.The New England journal of medicine · 2022 · Incidence of death or neurodevelopmental impairment was 52.5% in the erythropoietin group and 49.5% in the placebo group, relative risk 1.03, 95% CI 0.86 to 1.24, P=0.74.HumanCMaternal potassium-magnesium sulfate supplementation in low-protein diets improves performance and health of sows and suckling piglets.Animal nutrition (Zhongguo xu mu shou yi xue hui) · 2026 · n=120 · Weaning-to-estrus interval decreased linearly with increasing PMS supplementation, p=0.022.AnimalCDissecting the evolutionary forces shaping codon usage bias in SFTSV from eastern China: Insights from a previously underrepresented region.Virulence · 2026 · n=152 · Natural selection accounted for 52.8-91.4% of codon usage bias.In vitro